严重的芬太尼戒断与美德托米丁改相关:来自费城,宾夕法尼亚州的多中心研究
Journal of addiction medicine
|August 1, 2025
概括
在芬太尼中改梅德托米丁会导致严重戒断,与阿片类药物戒断不同. 对于这些患者,需要像德克斯梅德托米丁 (dexmedetomidine) 这样的积极疗法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 紧急医疗 紧急医疗
背景情况:
- 梅德托米丁是一种兽医的α2-上腺激动剂,在非法芬太尼中越来越多地被发现是伪造剂.
- 这种改与严重的戒断综合征有关,与典型的阿片类药物戒断不同.
研究的目的:
- 描述患者的临床特征和结果经历了退出medetomidine-adulterated芬太尼.
- 在这种情况下,要突出标准阿片类药物戒断管理的局限性.
主要方法:
- 在2024年9月至2025年4月期间,费城的209名患者的多中心病例系列.
- 纳入标准:报告的阿片类药物使用,阿片类药物戒断因严重的交感激活而复杂化,以及住院治疗.
- 数据包括人口统计,临床结果和毒理学测试在一个子集.
主要成果:
- 77.5%的患者需要进入ICU,20.1%需要输管.
- 传统的阿片类药物戒断治疗往往是无效的; 73.7%的人接受了德克斯梅德托米丁输液.
- 毒理学证实了百分之百的受试患者 (n=43) 服用芬太尼和梅德托米丁. 严重的并发症包括脑病变 (35.4%) 和心肌损伤 (28.7%).
结论:
- 暴露于美德托米丁伪造的芬太尼导致严重的戒断综合征,需要专门的管理.
- 临床医生必须认识到标准方案的不足,并考虑像德克斯梅托米丁这样的激进的α2-激动剂疗法.
- 调整临床和公共卫生策略至关重要,因为美德托米丁改可能会增加.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
437
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
437
Parenteral Anesthetics: Overview
199
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
199
Sedatives and Hypnotics Drugs: Miscellaneous Agents
243
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
243
Opioid Analgesics: Morphine and Other Natural Cogeners
366
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
366
Analgesia and Pain Management
803
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
803
Drug Abuse and Addiction: Pharmacological Phenomena
656
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
656


